NRX Pharmaceuticals, Inc. Depreciation
NRX Pharmaceuticals, Inc. (NRXP) reported Depreciation of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- NRX Pharmaceuticals, Inc. depreciation for the quarter ending 2026-06-30 was $100.00K, a 0.00% change year-over-year.
- NRX Pharmaceuticals, Inc. depreciation for the quarter ending 2026-03-31 was $20.00K, a 0.00% change year-over-year.
- NRX Pharmaceuticals, Inc. depreciation for the quarter ending 2025-12-31 was -$3.99M.
- NRX Pharmaceuticals, Inc. depreciation for the quarter ending 2025-09-30 was $2.00M.
- NRX Pharmaceuticals, Inc. depreciation for fiscal 2025 was $10.00K, a 0.00% change from fiscal 2024.
- NRX Pharmaceuticals, Inc. depreciation for fiscal 2024 was $10.00K, a 100.00% increase from fiscal 2023.
- NRX Pharmaceuticals, Inc. depreciation for fiscal 2023 was $5.00K, a 25.00% increase from fiscal 2022.
- NRX Pharmaceuticals, Inc. depreciation for fiscal 2022 was $4.00K, a 100.00% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-14 | $100.00K 10-Q · filed 2026-08-14 | -$3.87M derived: sum of 3 quarters · filed 2026-08-14 | -$1.87M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $20.00K 10-Q · filed 2026-05-15 | -$3.97M derived: sum of 2 quarters · filed 2026-05-15 | -$1.97M derived: sum of 3 quarters · filed 2026-05-15 | -$1.87M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -$3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$1.99M derived: sum of 2 quarters · filed 2026-03-23 | -$1.89M derived: sum of 3 quarters · filed 2026-08-14 | $10.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-14 | $2.10M derived: sum of 2 quarters · filed 2026-08-14 | $4.00M 10-Q · filed 2025-11-14 | $1.13M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-14 | $100.00K 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2025-08-18 | -$870.00K derived: sum of 3 quarters · filed 2026-08-14 | -$870.00K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $20.00K 10-Q · filed 2026-05-15 | $0.00 10-Q · filed 2025-05-15 | -$970.00K derived: sum of 2 quarters · filed 2026-05-15 | -$970.00K derived: sum of 3 quarters · filed 2026-05-15 | -$969.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$990.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | -$990.00K derived: sum of 2 quarters · filed 2026-03-23 | -$989.00K derived: sum of 3 quarters · filed 2026-03-23 | $10.00K 10-K · filed 2026-03-23 | $5.00K 10-K · filed 2025-03-14 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $1.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.00M 10-Q · filed 2025-11-14 | $4.00K 10-Q · filed 2024-11-14 | $3.00K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $2.00K 10-Q · filed 2025-08-18 | $3.00K derived: sum of 3 quarters · filed 2025-08-18 | $5.00K derived: sum of 4 quarters · filed 2025-08-18 | ||||
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-15 | $2.00K derived: sum of 2 quarters · filed 2025-05-15 | $4.00K derived: sum of 3 quarters · filed 2025-05-15 | $5.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $3.00K derived: sum of 2 quarters · filed 2025-03-14 | $4.00K derived: sum of 3 quarters · filed 2025-03-14 | $5.00K 10-K · filed 2025-03-14 | ||||
| 2023-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $3.00K derived: sum of 2 quarters · filed 2024-11-14 | $4.00K 10-Q · filed 2024-11-14 | $5.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $2.00K 10-Q · filed 2024-08-14 | $3.00K derived: sum of 3 quarters · filed 2024-08-14 | $4.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-14 | $2.00K derived: sum of 2 quarters · filed 2024-05-14 | $3.00K derived: sum of 3 quarters · filed 2024-05-14 | $4.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $2.00K derived: sum of 2 quarters · filed 2024-03-29 | $3.00K derived: sum of 3 quarters · filed 2024-03-29 | $4.00K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.00K derived: sum of 2 quarters · filed 2023-11-14 | $3.00K 10-Q · filed 2023-11-14 | $3.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.00K 10-Q · filed 2023-08-14 | $2.00K derived: sum of 3 quarters · filed 2023-08-14 | $3.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 | $1.00K derived: sum of 2 quarters · filed 2023-05-15 | $2.00K derived: sum of 3 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.00K derived: sum of 2 quarters · filed 2023-03-31 | $2.00K 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.00K 10-Q · filed 2022-11-14 | $1.60K 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-15 | $967.00 10-Q · filed 2021-08-16 | ||||||
| 2020-12-31 | $890.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $2.00K 10-K · filed 2022-03-31 | ||||||
| 2020-09-30 | $1.11K 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |